Final Guidance: Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--“Dose Banding”-2023/9/29

Document: Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products-2025/1/7

Page: Budesonide, gastro-resistant hard capsules, 3 mg, gastro- resistant granules, 9 mg product-specific bioequivalence guidance-2025/2/12

Document: Release notes - production release version 1.7.2514-3 - 21 March 2025 - Veterinary Medical Products Regulation: Union Product Database-2025/3/21

Document: Mandate, objectives and rules of procedure of the Scientific Advice Working Party (SAWP)-2025/4/22

Document: Draft guideline on the clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Revision 2-2025/6/4

Document: Annex II questions and answers – Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products-2025/7/10

Document: QRD PSUR annex IV template-2025/8/18

Page: Eligible patients and consumers organisations-2025/9/29

Page: Guidelines Consistency Group-2025/11/5